23andMe

23andMe is a leading consumer genetics and research company. Founded in 2006, the company’s mission is to help people access, understand, and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the world’s largest crowdsourced platform for genetic research, with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases, conditions, and traits. More information is available at www.23andMe.com Chapter 11 Notice: The deadline to file a proof of claim is July 14, 2025 at 11:59 pm CT if submitted electronically (or 4:59 pm CT if submitted by hardcopy). For more information on how to file a claim, please visit: https://customercare.23andme.com/hc/en-us/articles/31884991159319-Questions-Related-To-23andMe-s-Bar-Notice